Synchron is a clinical-stage neurotechnology company developing an endovascular brain-computer interface (BCI).

Cell Bauhaus is working to understand, predict, and alter cellular behaviour to harness the power of living organisms.

Porous Lane has developed highly permeable, environmentally friendly pathways that capture and reuse water.

Apromore has developed a collaborative process mining platform, allowing businesses to analyse their processes, and identify areas for optimisation. Acquired by Salesforce in 2025.

Harnessing the power of botanically-inspired therapeutics

exteRNA is developing first-in-class inhibitors for the treatment of cancer.

Proxima Bio is developing degraders to target incurable diseases.

Gallant Bio is a pre-clinical stage company developing first-in-class treatments targeting a novel mechanism in obesity and type 2 diabetes.

Intelligent Silicon is building a novel LLM architecture that promises to deliver orders of magnitude improvement in speed and processing efficiency, unlocking new use cases and making AI profitable. The company draws on insights from cognitive science, which enable rational design architecture decisions.